Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 310460-39-0 Chemical Structure| 310460-39-0

Structure of CPYPP
CAS No.: 310460-39-0

Chemical Structure| 310460-39-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CPYPP is a DOCK2 inhibitor which bounds to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro. It also inhibits DOCK1 and DOCK5 and exhibits selectivity over DOCK9.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CPYPP

CAS No. :310460-39-0
Formula : C18H13ClN2O2
M.W : 324.76
SMILES Code : O=C(C1=CC=CC2=CC=CC=C2Cl)NN(C3=CC=CC=C3)C1=O
English Name :4-(3-(2-Chlorophenyl)allylidene)-1-phenylpyrazolidine-3,5-dione
MDL No. :MFCD00980987

Safety of CPYPP

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SAS-DTX 10 µM 24 h Induced cytoplasmic vacuolization and suppressed cell viability Cell Biosci. 2024 Jun 10;14(1):78
OECM1-DTX 10 µM 24 h Induced cytoplasmic vacuolization and suppressed cell viability Cell Biosci. 2024 Jun 10;14(1):78
NCI-H1299 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
PANC-1 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
U-87 MG 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
DBTRG-05MG 10 µM 24 h Induced cytoplasmic vacuolization and cell death Cell Biosci. 2024 Jun 10;14(1):78
MDA-MB-435 10 µM 24 h Induced cytoplasmic vacuolization and cell death, inhibited cell proliferation and clonogenic activity Cell Biosci. 2024 Jun 10;14(1):78
MDA-MB-231 10 µM 24 h Induced cytoplasmic vacuolization and cell death, inhibited cell proliferation and clonogenic activity Cell Biosci. 2024 Jun 10;14(1):78
human peripheral blood neutrophils 100 μM 60 min inhibited fMLF-induced Rac2 activation, chemotaxis, and ROS production J Immunol. 2014 Dec 1;193(11):5660-7
RCC7T/E 1–100μM 24 h Measure cell viability, EC50 was 16μM Prostate. 2020 Sep;80(13):1045-1057
VCaP 1–100μM 24 h Measure cell viability, EC50 was 31–35μM Prostate. 2020 Sep;80(13):1045-1057
MDA-PCa2b 1–100μM 24 h Measure cell viability, EC50 was 31–35μM Prostate. 2020 Sep;80(13):1045-1057
CD3+ T cells 100 μM 2 h To evaluate the effect of CPYPP on chemotaxis of CD3+ T cells under CXCL12 stimulation. Results showed that CPYPP significantly inhibited CXCL12-induced chemotaxis (FC=0.57, P=1.0×10−7). Nature. 2022 Sep;609(7928):754-760
pDCs 100 μM 12 h To evaluate the effect of CPYPP on IFNα production by pDCs under CpG stimulation. Results showed that CPYPP significantly reduced IFNα production (FC=5.5×10−5, P=0.0038). Nature. 2022 Sep;609(7928):754-760

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SCID mice Breast cancer orthotopic xenograft model Intraperitoneal injection 30 mg/kg Daily for 14 days Significantly suppressed tumor growth and induced tumor cell vacuolization Cell Biosci. 2024 Jun 10;14(1):78

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.40mL

3.08mL

1.54mL

30.79mL

6.16mL

3.08mL

References

 

Historical Records

Categories